What are the recommended first‑line and alternative treatment regimens for Helicobacter pylori infection, including options for macrolide resistance, penicillin allergy, pregnancy, and treatment failure?

H. pylori Treatment Recommendations

For treatment-naive patients, 14-day bismuth quadruple therapy (BQT) is the preferred first-line regimen when antibiotic susceptibility is unknown. 1

First-Line Treatment Options

Primary Recommendation: Bismuth Quadruple Therapy (14 days)

• Bismuth subsalicylate (e.g., Pepto-Bismol®) 2 tablets or capsules 4 times daily 30 minutes before meals
• Tetracycline HCl 500 mg 4 times daily 30 minutes after meals
• Metronidazole 500 mg 4 times daily 30 minutes after meals
• High-dose PPI twice daily (esomeprazole or rabeprazole 20-40 mg preferred) 30 minutes before meals 2, 1

This regimen achieves >85% eradication rates and is effective regardless of clarithromycin resistance patterns, which now exceed 15% in most North American regions 1, 3.

Alternative formulation: Pylera® (combination capsules) can be used but costs approximately $70 in Europe; generic tetracycline in the US costs ~$660 retail but can be obtained for <$100 with discount coupons 2.

Alternative First-Line Options

Rifabutin Triple Therapy (14 days) - suitable empiric alternative without penicillin allergy:

• Rifabutin 150 mg twice daily
• Amoxicillin 1 g three times daily (minimum 2 g daily total)
• High-dose PPI (esomeprazole or rabeprazole 40 mg) twice daily 2, 1

Rifabutin resistance is rare, making this an excellent option. Talicia® is an FDA-approved formulation but costs ~$700; generic rifabutin can be obtained for ~$150 with coupons 2.

Vonoprazan-based dual therapy (14 days) - emerging option where available:

• Vonoprazan (potassium-competitive acid blocker)
• Amoxicillin high-dose 1, 4

Critical Treatment Principles

Avoid These Regimens Empirically

Do NOT use clarithromycin triple therapy empirically - only use if susceptibility testing confirms sensitivity. Clarithromycin resistance exceeds 30% in North America 1, 5. The guidelines explicitly state concomitant, hybrid, reverse hybrid, and sequential therapies are now considered obsolete because they include antibiotics offering no therapeutic benefit while increasing global antimicrobial resistance 2.

PPI Selection Matters

Avoid pantoprazole - it has significantly lower potency (40 mg pantoprazole = only 9 mg omeprazole equivalent). Prefer esomeprazole or rabeprazole 20-40 mg twice daily, as these provide superior acid suppression critical for amoxicillin-containing regimens 2, 6.

Penicillin Allergy Management

For patients reporting penicillin allergy:

1. Consider allergy testing unless history of anaphylaxis - this can "delist" the allergy and enable amoxicillin use 6

2. If true penicillin allergy confirmed, use:

   • Minocycline-based BQT (14 days): Minocycline 100 mg twice daily + metronidazole 400 mg 4 times daily + bismuth + PPI 7
   • Cefuroxime-based BQT (14 days): Cefuroxime 500 mg twice daily + metronidazole 400 mg 4 times daily + bismuth + PPI 7

These regimens achieved 82-84% eradication rates in penicillin-allergic patients with good safety profiles 7.

Second-Line Treatment (After First Failure)

If BQT Failed First-Line

Choose between:

• Levofloxacin triple therapy (14 days): Levofloxacin 500 mg daily + amoxicillin 1 g twice daily + high-dose PPI twice daily
• Rifabutin triple therapy (14 days) as described above 6, 1

Critical caveat: Only use levofloxacin if patient has no prior fluoroquinolone exposure - resistance develops rapidly with any prior use 6.

If BQT Not Previously Used

Optimized BQT for 14 days remains the preferred option 1.

Treatment After Multiple Failures

After two failed therapies with confirmed adherence, antimicrobial susceptibility testing should be performed to guide subsequent regimens 6, 1.

If susceptibility testing unavailable, use antibiotics not previously tried where resistance is rare:

• Amoxicillin (resistance remains rare)
• Tetracycline (resistance rare)
• Rifabutin (resistance rare)
• Bismuth 6, 3

Pregnancy Considerations

Treatment during pregnancy requires careful consideration. Amoxicillin-based regimens are preferred as tetracycline is contraindicated. Consider deferring treatment until after pregnancy unless urgent indication exists.

Optimizing Treatment Success

Dosing Strategies

• Amoxicillin: Use ≥2 g daily divided 3-4 times daily to avoid low trough levels 6
• Metronidazole: Use 1.5-2 g daily in divided doses with bismuth to overcome resistance 6
• Duration: Always use 14 days - longer durations significantly improve eradication versus 7-10 days 6

Addressing Adherence

Explain the complete regimen complexity upfront, expected side effects, and importance of completing full course. Barriers to adherence should be explored before prescribing 6.

Acid Suppression

Inadequate acid suppression is a major cause of failure. Use high-dose, potent PPIs (not metabolized by CYP2C19 if possible) or vonoprazan where available 6, 3.

Common Pitfalls to Avoid

1. Using clarithromycin or levofloxacin empirically - resistance rates are too high
2. Choosing pantoprazole - inadequate acid suppression
3. 7-day treatment courses - insufficient duration
4. Failing to confirm eradication - test-of-cure is mandatory 4-8 weeks post-treatment
5. Not reviewing prior antibiotic exposures - any prior macrolide or fluoroquinolone use predicts resistance 6

Adjunctive Therapies

Probiotics can reduce antibiotic-related adverse events and may modestly improve eradication rates, though evidence for refractory cases remains experimental 6, 3, 4. Multi-strain formulations show the most consistent benefit 8.